Is the pharma market, which is currently at INR2.17 lakh crore (USD25.8 billion), getting too crowded? While some industry experts believe a few clear signs of fatigue have emerged, many say it is not a doom scenario yet and a rebound may not be far.
Related Posts
Rajendra Badwe: How Rajendra Badwe is making cancer treatment affordable by repurposing easily available drugs
Dr. Rajendra Achyut Badwe, Director, Tata Memorial Center. Synopsis Badwe, director of Mumbai’s Tata Memorial Centre, has reset the rules…
cipla: Leap of faith: how Cipla veteran Nikhil Chopra got JB Pharma out of the woods, on to a growth path
Nikhil Chopra, CEO, JB Chemicals and Pharmaceuticals Ltd. Image credit: Special Arrangement Synopsis When PE firm KKR took control of…
J-Labs: For scientific breakthroughs, India needs its own J-Labs…or lose the race
Credit: illustration by Sadhana Saxena via Ai Synopsis Something as cool as a J-Labs can be a welcome step. From…
